NewEdge Advisors’s Revolution Medicines RVMD Stock Holding History

NewEdge Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$526K	Buy	+2,806	New	+$410K	﹤0.01%	2106
2025 Q4	–	Sell	-21	Closed	-$981	–	4353
2025 Q3	$981	Hold	21	–	–	﹤0.01%	3884
2025 Q2	$773	Hold	21	–	–	﹤0.01%	3750
2025 Q1	$743	Hold	21	–	–	﹤0.01%	3660
2024 Q4	$919	Hold	21	–	–	﹤0.01%	3575
2024 Q3	$952	Hold	21	–	–	﹤0.01%	3520
2024 Q2	$815	Hold	21	–	–	﹤0.01%	3507
2024 Q1	$677	Hold	21	–	–	﹤0.01%	3554
2023 Q4	$602	Hold	21	–	–	﹤0.01%	3519
2023 Q3	$581	Hold	21	–	–	﹤0.01%	3235
2023 Q2	$562	Hold	21	–	–	﹤0.01%	3305
2023 Q1	$455	Sell	21 -75	-78%	-$1.85K	﹤0.01%	3247
2022 Q4	$1.79K	Buy	+96	New	+$2.04K	﹤0.01%	2869

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

NewEdge Advisors's RVMD Position: Q2 2026 in Review

NewEdge Advisors opened a new position in Revolution Medicines (RVMD) in Q2 2026: 2,806 shares worth $526K. The stake represents ﹤0.01% of the portfolio and ranks #2106 among its holdings. This is a return to the name: NewEdge Advisors previously reported a position in RVMD as recently as Q3 2025.

NewEdge Advisors first reported a position in RVMD in Q4 2022 and has held it in 13 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

NewEdge Advisors held 2,806 shares of Revolution Medicines worth $526K as of Q2 2026.
Revolution Medicines was a new NewEdge Advisors position in Q2 2026.
Revolution Medicines made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2106 holding.
NewEdge Advisors first reported a position in Revolution Medicines in Q4 2022 and has held it in 13 quarters since.
691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.